Clinical Trial Update: Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults [NA]

View source ↗

Summary

A completed clinical trial assessing the impact of acetaminophen on the performance of the Guardian Sensor (3) in adults with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Acetaminophen (Acetaminophen)
• Guardian Sensor (3)

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2023-09-08